Vax Patent Battles Heat Up As Attention On Pandemic Wanes
By Ryan Davis · August 20, 2024, 5:33 PM EDT
Already a subscriber? Click here to login
Analysis
By Ryan Davis · August 20, 2024, 5:33 PM EDT
Already a subscriber? Click here to login
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Delaware
Patent
February 28, 2022
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., et al
Delaware
Patent
March 17, 2022
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al
Delaware
Patent
March 17, 2022
ModernaTX, Inc. et al v. Pfizer Inc. et al
Massachusetts
Patent
August 26, 2022
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
New Jersey
Patent
April 04, 2023
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
New Jersey
Patent
April 04, 2023
CureVac SE, et al. v. BioNTech SE, et al.
Virginia Eastern
Patent
May 19, 2023
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
Delaware
Patent
May 26, 2023
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
Delaware
Patent
May 26, 2023
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Appellate - Federal Circuit
830 Patent Infringement (Fed. Qst.)
September 07, 2023
GlaxoSmithKline Biologicals SA et al v. Pfizer Inc. et al
Delaware
Patent
April 25, 2024
Acuitas Therapeutics Inc. et al v. Alnylam Pharmaceuticals, Inc.
Delaware
Patent
July 12, 2024
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA v. BIONTECH SE et al
Pennsylvania Eastern
Contract: Other
August 05, 2024
July 02, 2025
The Biggest Patent Rulings Of 2025: A Midyear ReportJuly 01, 2025
Fed. Circ. Faults PTAB Ax Of Patent On Bausch Eye DropsJune 30, 2025
Justices Won't Eye Claim Fed. Circ. Revived Waived ArgumentJune 06, 2025
Justices Reject Eligibility Appeal On Telemedicine PatentsMay 14, 2025
Alnylam Halts Patent Row Over Pfizer, BioNTech COVID-19 VaxApril 02, 2025
5 Fed. Circ. Clashes To Watch This MonthJanuary 02, 2025
Issa Again Selected To Lead House IP SubcommitteeDecember 16, 2024
The Biggest Patent Decisions Of 2024November 21, 2024
In Tight Vote, Senate Panel OKs Bill To Set New PTAB LimitsOctober 28, 2024
Judge Leaves Patent Case After Fed. Circ. Undoes Ruling